LKFT · Lakefront Biotherapeutics NV
$27.72
-0.43 (-1.53%)
At close · Jul 29
Market Cap
$1.82B
Shares
65.48M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-07-28 | — | |
| 6-K | 2026-07-21 | — | |
| 6-K | 2026-07-15 | 2026-07-14 | |
| 6-K | 2026-07-13 | — | |
| 6-K | 2026-07-07 | — | |
| 6-K | 2026-06-30 | — | |
| 6-K | 2026-06-30 | 2026-06-29 | |
| 6-K | 2026-06-24 | 2026-06-23 | |
| 6-K | 2026-06-16 | — | |
| 6-K | 2026-06-09 | 2026-06-08 | |
| 6-K | 2026-06-09 | — | |
| 6-K | 2026-06-05 | 2026-06-04 | |
| 6-K | 2026-05-27 | 2026-05-26 | |
| 6-K | 2026-05-06 | — | |
| 6-K | 2026-04-29 | 2026-04-28 | |
| 6-K | 2026-03-31 | — | |
| 6-K | 2026-03-30 | — | |
| 20-F | 2026-03-26 | 2025-12-31 | |
| 6-K | 2026-03-24 | 2026-03-23 | |
| 6-K | 2026-03-17 | — | |
| 6-K | 2026-03-10 | — | |
| 6-K | 2026-03-06 | — | |
| 6-K | 2026-03-05 | — | |
| 6-K | 2026-03-04 | — | |
| 6-K | 2026-02-23 | — | |
| 6-K | 2026-02-19 | — | |
| 6-K | 2026-02-17 | 2026-02-16 | |
| 6-K | 2026-02-10 | — | |
| 6-K | 2026-01-05 | — | |
| 6-K | 2025-12-18 | — | |
| 6-K | 2025-12-08 | — | |
| 6-K | 2025-11-26 | — | |
| 6-K | 2025-11-06 | 2025-11-05 | |
| 6-K | 2025-11-03 | — | |
| 6-K | 2025-10-30 | — | |
| 6-K | 2025-10-24 | 2025-10-23 | |
| 6-K | 2025-10-21 | — | |
| 6-K | 2025-10-16 | — | |
| 6-K | 2025-10-01 | — | |
| 6-K | 2025-08-07 | — | |
| 6-K | 2025-08-06 | — | |
| 6-K | 2025-07-24 | 2025-07-23 | |
| 6-K | 2025-07-24 | — | |
| 6-K | 2025-07-23 | — | |
| 6-K | 2025-06-25 | 2025-06-23 | |
| 6-K | 2025-06-20 | 2025-06-18 | |
| 6-K | 2025-06-13 | 2025-06-12 | |
| 6-K | 2025-05-28 | — | |
| 6-K | 2025-05-14 | — | |
| 6-K | 2025-05-13 | — |
Showing 1–50 of 234 filings
Key facts
CIK
1421876
CUSIP
36315X101
13F (30d)
16 filings
14 filers
Visit website
Investor relations